PVI
GSK icon

Pura Vida Investments’s GSK GSK Stock Holding History

Pura Vida Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-156,500
Closed -$8.25M – 78
2017
Q1 		$8.25M Buy
+156,500
New +$7.94M 2.44% 10
2016
Q4 		– Sell
-120,286
Closed -$6.49M – 76
2016
Q3 		$6.49M Buy
120,286
+40,986
+52% +$2.25M 1.97% 22
2016
Q2 		$4.3M Buy
+79,300
New +$4.18M 1.83% 22

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pura Vida Investments's GSK Position: Q2 2017 in Review

Pura Vida Investments sold out of GSK (GSK) in Q2 2017, closing a stake of 156,500 shares — an estimated $8.25M sold.

Pura Vida Investments first reported a position in GSK in Q2 2016 and held it in 3 quarters. The position peaked at $8.25M in Q1 2017. 779 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

  • Pura Vida Investments reported no remaining GSK position as of Q2 2017 after selling out during the quarter.
  • Pura Vida Investments sold 156,500 GSK shares in Q2 2017, an estimated $8.25M.
  • Pura Vida Investments first reported a position in GSK in Q2 2016 and held it in 3 quarters.
  • Pura Vida Investments's GSK position peaked at $8.25M in Q1 2017.
  • 779 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Pura Vida Investments's 13F filing for Q2 2017, filed 14 Aug 2017.